-
-
Featured Care Areas
Please check with your insurance provider for more information, and for their most up-to-date list of panel doctors.
^Specialists may qualify to be on the Extended Panel (EP). You may enjoy selected panel benefits depending on your policy and riders.
Dr John Chia is a medical oncologist at Mount Elizabeth Novena Hospital, Singapore.
His subspeciality interests include ovarian, endometrial, cervical, breast and colorectal cancers, including the management of rare tumours such as melanoma, uterine sarcomas and germ cell tumours. He manages complex gynae-oncology.
Dr Chia was the former chief of the gynaecology oncology service in the division of medical oncology at the National Cancer Centre Singapore.
He graduated from the National University of Singapore and obtained his membership of the Royal College of Physicians of Edinburgh, UK. He was actively engaged with the then nascent field of immunotherapy for solid cancers and was involved with the leadership or development of seven immunotherapy clinical trials in Singapore. He undertook his fellowship training in the development of dendritic cancer vaccines, adoptive T-cell therapy, and immune biomarker monitoring for cancers. He later completed a second fellowship at the Royal Marsden Hospital, UK for the advanced management of gynaecological cancers.
Dr Chia is active in clinical trial research and has developed numerous research protocols and trials for ovarian, cervical, colorectal, nasopharyngeal and breast cancer. He has published widely in international journals and holds numerous local and international research grants for research in immune checkpoint inhibitors, cancer vaccines, T-cell therapy, aspirin chemoprevention, and small molecule inhibitors for cancer. He has more than 20 years of experience practising medicine.
He is the vice-president and founding board member of the Gynaecologic Cancer Group Singapore. He was also the former adjunct associate professor at Duke-NUS Medical School. He lectures widely, including in Japan, Korea, Hong Kong, China, UK and does plenary symposia lectures in Germany, Australia and ESMO Asia. Locally he has helped to write the Singapore ovarian and uterine cancer management guidelines. He is an exco member of the Mount Elizabeth Novena Hospital medical board and the ex-chair of its neoplasia committee. He is a member of the Parkway independent ethics committee, that oversees the review and approval of clinical trials, and recruits individuals for novel therapies in Parkway Healthcare.
Bachelor of Medicine, Bachelor of Surgery
Member of the Royal College of Physicians, UK
Fellow of the Academy of Medicine, Singapore